How Do Semaglutide and Liraglutide Work at the Molecular Level to Fight Obesity? | Research

The takeaway

Semaglutide and liraglutide combat obesity through multiple molecular mechanisms including appetite suppression, improved insulin secretion, enhanced energy expenditure, and better lipid metabolism.

5 pathways
molecular mechanisms through which GLP-1 RAs combat obesity

What the researchers found

Semaglutide and liraglutide act through five key molecular pathways: appetite regulation via hypothalamic signaling, enhanced insulin secretion, glucose homeostasis, increased energy expenditure, and improved lipid metabolism.

Why it matters

Understanding exactly how GLP-1 drugs work at the molecular level helps researchers develop next-generation obesity treatments and helps clinicians predict which patients will benefit most from these therapies.

The numbers in context

Obesity is associated with cardiovascular disease, type 2 diabetes, hypertension, and certain cancers. Global prevalence is increasing.

How the study worked

Minireview synthesizing published research on the molecular mechanisms of action of semaglutide and liraglutide in obesity-related metabolic pathways.

Who was studied

Adults with obesity

What this study cannot tell us

Minireview format without systematic search methodology; focuses primarily on semaglutide and liraglutide without comprehensive comparison to newer GLP-1 agents; does not cover emerging combination therapies like tirzepatide.

How to read the evidence

Strong as a review, synthesizing well-established molecular biology research and clinical trial data on two FDA-approved medications.

When this study was published

Published in 2024, providing a current overview of established and emerging GLP-1 receptor agonist mechanisms.

The bigger picture

As GLP-1 receptor agonists become the most impactful obesity medications in decades, this mechanistic understanding provides the foundation for developing even more targeted and effective treatments in the expanding weight management field.

Questions still open

Which of the five molecular pathways contributes most to the weight loss effects of these drugs?
How do individual genetic variations in GLP-1 receptor expression affect treatment response?
Can these molecular insights guide development of oral GLP-1 formulations with equivalent efficacy?

Common questions

How do semaglutide and liraglutide actually cause weight loss?

They activate GLP-1 receptors throughout your body, which suppresses appetite by signaling fullness to your brain, boosts insulin to control blood sugar, increases how much energy your body burns, and improves how your body processes fats.

What's the difference between how semaglutide and liraglutide work?

They both target the same GLP-1 receptor and share the same core mechanisms. The main difference is structural — semaglutide has modifications that make it last longer in the body, allowing once-weekly dosing versus liraglutide's daily injection.

Read the original research

Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity.

Frontiers in nutrition, 11, 1398059

View on PubMed ↗Publisher’s paper ↗

Citation

Tamayo-Trujillo, Rafael; Ruiz-Pozo, Viviana A; Cadena-Ullauri, Santiago; Guevara-Ramírez, Patricia; Paz-Cruz, Elius; Zambrano-Villacres, Raynier; Simancas-Racines, Daniel; Zambrano, Ana Karina. (2024). Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity.. Frontiers in nutrition, 11, 1398059. https://doi.org/10.3389/fnut.2024.1398059